You are here

  • Home
  • Archive
  • Volume 34, Issue Suppl 3
  • EV344/#770  Surufatinib combined with toripalimab for the treatment of recurrent ovarian clear cell carcinoma: a prospective single center, single-arm phase II clinical trial

Citation Tools

Article menu
Download PDFPDF
E-Poster Viewing Abstracts
AS10. Ovarian cancer
EV344/#770  Surufatinib combined with toripalimab for the treatment of recurrent ovarian clear cell carcinoma: a prospective single center, single-arm phase II clinical trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ye S, Fu Y, Liu S, et al
EV344/#770  Surufatinib combined with toripalimab for the treatment of recurrent ovarian clear cell carcinoma: a prospective single center, single-arm phase II clinical trial
International Journal of Gynecologic Cancer 2024;34:A262-A263.